NEWS
NEWS
From December 16 to 18, 2025, the 2025 Annual Conference of the China Acacemy of Arbitration Law and the 18th China Arbitration and Judiciary Forum were successfully held in Changsha, Hunan Province. The conference was themed “Building International Commercial Arbitration Centers in the New Era.” It was hosted by the China Acacemy of Arbitration Law and organized by the Hunan Chamber of Commerce of the China Chamber of International Commerce, with support from the All China Lawyers Association, the International Commercial Dispute ...
On October 24, 2025, the Guangzhou Arbitration Commission (hereinafter referred to as the "GZAC") held its first hearing at its London Hearing Center, which was successfully concluded. With the presiding arbitrator announcing the end of the hearing, this milestone marks a substantive step forward in GZAC’ s internationalization process.The case involved a cross-border financial dispute, with parties and related assets in Hong Kong and the United Kingdom, highlighting its distinct international nature. The arbitral tribunal was composed of three arbitrators from China...
Du 16 au 18 juin 2025, le Congrès annuel de l’Association Henri Capitant s’est tenu avec succès à l’Université nationale de Séoul en Corée du Sud. Placé sous le thème central de l’« Intelligence artificielle face à la responsabilité civile et au droit d’auteur ». Cette édition événement...
On July 23, 2025, the Mid-Summer Appointment | SCIA Open Day: Young Lawyers’ Session was held at the Qianhai International Arbitration Tower (SCIA TOWER). The event was hosted by the Shenzhen Court of International Arbitration (South China International Economic and Trade Arbitration Commission, Greater Bay Area International Arbitration Center, abbreviated in English as SCIA), and attended by over 200 young lawyers from 130 law firms.Zhong Yiqi, Associate Legal Counsel of SCIA’s Department of International Cooperation and Development...
Recently, Jiangsu issued the nation's first overseas intellectual property protection guidelines for the biopharmaceutical sector, filling a domestic gap in guidance for Chinese biopharmaceutical companies expanding overseas. These guidelines provide systematic, professional, and comprehensive guidance on overseas IP protection for China's "going global" biopharmaceutical enterprises.Focusing on industry-specific characteristics, the guidelines comprehensively outline international IP protection treaties for biopharmaceuticals, market access and ...